🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on the fourteenth of October at 51 years old after a personal fight with pancreatic cancer.

“The shining star of our household has dimmed his light for us in this life,” his relatives confirmed. “After a lengthy and brave battle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, known to his followers around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his pioneering neo-soul sound and collaborations with renowned musicians.

He released his debut album, “Brown Sugar,” in 1995 to instant praise. The album achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum soon after, and received multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The album debuted at No. 1 on both the R&B charts and the Billboard 200. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the artist, famously bare to his waist, performing straight into the lens.

D’Angelo stepped back from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious vehicle accident that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the soul music rankings and a award for Top R&B Record.

Once more, in his own mysterious fashion, D’Angelo made only a few public outings in the following years.

The musician was announced as a headliner for the 2025 music event, but his appearance was called off, citing an “unexpected health issue.”

Even though information is limited about D’Angelo’s health in the months before his passing, he had reportedly been hospitalized for months and in palliative care for two weeks.

D’Angelo’s passing is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and least preventable types of the illness, on a gifted artist whose life was cut short.

“We are saddened that he can only leave cherished moments with his loved ones, but we are forever thankful for the heritage of extraordinarily moving music he has left us,” his family expressed.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic cancer impacts the pancreas, a small organ that produces the hormone insulin and is vital in digestion, among other functions. The size and location of the organ in the body make it more challenging to detect malignancy.

Although this cancer accounts for only about 3% of cancer diagnoses annually in the United States, it is responsible for 7% of cancer deaths.

Nearly seventy thousand individuals will be diagnosed with pancreatic cancer and roughly 52,000 will succumb to the illness in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have limited and poor therapies, and a smaller window to make a significant difference on the well-being of patients,” said a cancer specialist.

Since this disease seldom produces early symptoms, it’s often diagnosed only after the condition is late-stage. Although a individual has indicators they are usually vague and may be mistaken for a number of everyday ailments.

“As of yet, there is no effective method to identify pancreatic cancer in the initial phases, apart from listening to your body and consulting your physician if there are new or unusual symptoms,” explained a medical director.

Common symptoms of this disease encompass:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• nausea

At age 51, D’Angelo’s demise is an outlier, as this malignancy is most common in individuals in the sixty-five to seventy-five range. However, numerous malignancies, including pancreatic cancer, have become increasingly prevalent among younger people.

“Pancreatic cancer identified prior to fifty is considered uncommon, yet concerningly, clinicians are beginning to see a growing number of younger patients suffering from this disease,” commented a specialist.

Family History Affects Cancer Risk

Without effective screening tools for pancreatic cancer, experts stressed the importance of knowing your family’s cancer history. Certain contributing elements, such as tobacco use and obesity also play a role in the development of pancreatic cancer.

African Americans have the greatest occurrence of this malignancy in the United States and are most likely to be found to have untreatable disease.

“The initial action toward lowering one’s risk of this condition is understanding individual susceptibility. People should review their family history, genetic background, and medical conditions, such as blood sugar disease, chronic pancreatitis, or overweight that may raise their vulnerability,” said a specialist.

Hereditary elements are linked to as much as 10% of all pancreatic cancer cases. If a relative in your family has had pancreatic cancer, you may want to consider genetic testing.

“For people with a family history of pancreatic cancer or those carrying high risk genetic mutations, screening may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to detect early changes in the pancreas,” he clarified.

For those wishing to reduce their risk, habit adjustments may have an effect. The best action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy drinking is associated with pancreatitis, a contributing element for this malignancy, so limiting or avoiding alcohol may help reduce your risk.

Controlling your body mass or shedding pounds may also help decrease your susceptibility. People with obesity are 20% more likely to develop this disease. Pancreatic cancer also is more frequent in people with diabetes, and weight loss can also reduce the risk of type 2 diabetes.

Despite this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer mixed drug treatments. There are emerging targeted therapies that are already making an impact,” said a specialist.

For numerous people, however, awareness about this uncommon but {dev